The clinical impact of the detection of potential etiologic pathogens of community-acquired pneumonia
- PMID: 26341706
- PMCID: PMC7125660
- DOI: 10.1016/j.diagmicrobio.2015.08.001
The clinical impact of the detection of potential etiologic pathogens of community-acquired pneumonia
Abstract
The etiology of community-acquired pneumonia (CAP) is determined in less than half of the patients based on cultures of sputum and blood plus testing urine for the antigens of Streptococcus pneumoniae and Legionella pneumophila. This study added nasal polymerase chain reaction (PCR) probes for S. pneumoniae, Staphylococcus aureus, and respiratory viruses. Serum procalcitonin (PCT) levels were measured. Pathogens were identified in 78% of the patients. For detection of viruses, patients were randomized to either a 5-virus laboratory-generated PCR bundle or the 17-virus FilmArray PCR platform. The FilmArray PCR platform detected more viruses than the laboratory-generated bundle and did so in less than 2 hours. There were fewer days of antibiotic therapy, P = 0.003, in CAP patients with viral infections and a low serum PCT levels.
Keywords: Community-acquired pneumonia; Diagnostic bundles; FilmArray; Molecular diagnostics; Procalcitonin.
Copyright © 2015 Elsevier Inc. All rights reserved.
Figures


References
-
- Becker K.L., Snider R., Nylen E.S. Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit Care Med. 2008;36:941–952. - PubMed
-
- Branche A.R., Walsh E.E., Vargas R., Hulbert B., Formica M.A., Baran A. Serum procalcitonin and viral testing to guide antibiotic use for respiratory infections in hospitalized adults: a randomized controlled trial. J Infect Dis. 2015 doi: 10.1093/infdis/jiv253. (Epub ahead of print) - DOI - PMC - PubMed
-
- Gilbert D.N. Procalcitonin as a biomarker in respiratory tract infection. Clin Infect Dis. 2011;52:S362. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous